Myc suppression of Nfkb2 accelerates lymphomagenesis.

Myc suppression of Nfkb2 accelerates lymphomagenesis.
复制标题

DOI:
10.1186/1471-2407-10-348
复制
发表时间:
2010-07-02
期刊:
影响因子:
3.8
通讯作者:
Cleveland JL
Cleveland JL
中科院分区:
医学2区
文献类型:
--
作者:
Keller U;Huber J;Nilsson JA;Fallahi M;Hall MA;Peschel C;Cleveland JL

文献摘要

参考文献

被引文献

相似文献

c-Myc表达失调是几种人类癌症的标志,其中它促进增殖和侵袭性肿瘤表型。Myc过表达与Rel/NF-κB活性降低相关,Rel/NF-κ B是控制免疫应答、细胞存活和转化的转录因子,并且在癌症中经常发生改变。在淋巴恶性肿瘤中,Rel/NF-κB家族成员NF-κ B2通过染色体易位或缺失而改变,并且NF-κB2的C末端锚蛋白结构域的缺失增强淋巴细胞增殖。评估癌前Eμ-Myc转基因B细胞、Eμ-Myc淋巴瘤和人伯基特淋巴瘤样品的Nfkb 2表达。Nfkb 2对Myc驱动的细胞凋亡、增殖和淋巴瘤发生的贡献在体内进行了遗传学测试。在此我们报道了Myc癌蛋白在体外抑制小鼠原代成纤维细胞和B细胞中Nfkb 2的表达,以及在体内抑制人Burkitt淋巴瘤(BL)的Eμ-Myc转基因小鼠模型中Nfkb 2的表达。Myc对NFKB 2的抑制也在原发性人BL中得到证实。启动子-报告基因分析表明Myc介导的Nfkb 2抑制发生在转录水平。在体内测试了Nfkb 2对Myc驱动的淋巴瘤发生的贡献,其中Nfkb 2的缺失显示通过损害Myc的凋亡反应来加速Eμ-Myc转基因小鼠中的淋巴瘤发展。Nfkb 2被c-Myc抑制并利用Myc驱动的淋巴瘤发生。因此,这些数据将Myc驱动的淋巴瘤发生与非经典NF-κB途径联系起来。
Deregulated c-Myc expression is a hallmark of several human cancers where it promotes proliferation and an aggressive tumour phenotype. Myc overexpression is associated with reduced activity of Rel/NF-κB, transcription factors that control the immune response, cell survival, and transformation, and that are frequently altered in cancer. The Rel/NF-κB family member NFKB2 is altered by chromosomal translocations or deletions in lymphoid malignancies and deletion of the C-terminal ankyrin domain of NF-κB2 augments lymphocyte proliferation. Precancerous Eμ-Myc-transgenic B cells, Eμ-Myc lymphomas and human Burkitt lymphoma samples were assessed for Nfkb2 expression. The contribution of Nfkb2 to Myc-driven apoptosis, proliferation, and lymphomagenesis was tested genetically in vivo. Here we report that the Myc oncoprotein suppresses Nfkb2 expression in vitro in primary mouse fibroblasts and B cells, and in vivo in the Eμ-Myc transgenic mouse model of human Burkitt lymphoma (BL). NFKB2 suppression by Myc was also confirmed in primary human BL. Promoter-reporter assays indicate that Myc-mediated suppression of Nfkb2 occurs at the level of transcription. The contribution of Nfkb2 to Myc-driven lymphomagenesis was tested in vivo, where Nfkb2 loss was shown to accelerate lymphoma development in Eμ-Myc transgenic mice, by impairing Myc's apoptotic response. Nfkb2 is suppressed by c-Myc and harnesses Myc-driven lymphomagenesis. These data thus link Myc-driven lymphomagenesis to the non-canonical NF-κB pathway.
DOI: 10.1016/s1097-2765(03)00102-3
发表时间: 2003-04-01
期刊: MOLECULAR CELL
影响因子: 16
作者:
Baudino, TA;Maclean, KH;Cleveland, JL
通讯作者: Cleveland, JL
DOI: 10.1038/sj.onc.1203432
发表时间: 2000-03-02
期刊: ONCOGENE
影响因子: 8
作者:
Kim, KE;Gu, CY;Rabson, AB
通讯作者: Rabson, AB
DOI: 10.1056/nejmoa055759
发表时间: 2006-06-08
影响因子: 158.5
作者:
Dave, Sandeep S.;Fu, Kai;Staudt, Louis M.
通讯作者: Staudt, Louis M.
DOI: 10.1016/s1074-7613(01)00088-7
发表时间: 2001-01-01
期刊: IMMUNITY
影响因子: 32.4
作者:
de Alboran, IM;O'Hagan, RC;Alt, FW
通讯作者: Alt, FW
DOI: 10.1084/jem.187.2.185
发表时间: 1998-01-19
影响因子: 15.3
作者:
Caamano, J H;Rizzo, C A;Durham, S K;Barton, D S;Raventos-Suarez, C;Snapper, C M;Bravo, R
通讯作者: Bravo, R